Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New laser treatment aims to control recurrent prostate cancer

NCT ID NCT03067051

First seen May 02, 2026 · Last updated May 21, 2026 · Updated 4 times

Summary

This study tests a new treatment for men whose prostate cancer has come back after radiation therapy. The treatment uses lasers and a light-sensitive drug to destroy cancer cells while sparing healthy tissue. The goal is to see if it is safe and effective, and to find the best dose. About 66 men who cannot have surgery or more radiation will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact

  • Princess Margaret Cancer Centre

    RECRUITING

    Toronto, Ontario, ON M5G 2M9, Canada

    Contact Phone: •••-•••-••••

    Contact

  • Reader in Urology, University College London & Honorary Consultant Urological Surgeon, University College London Hospitals Trust

    RECRUITING

    London, W1W 7TS, United Kingdom

    Contact

    Contact

  • Skåne University Hospital

    RECRUITING

    Malmö, Skåne County, Sweden

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.